Analysts who follow Lyell Immunopharma Inc (LYEL) on average expect it to rise 259.55% over the next twelve months. Those same analysts give the stock an average rating of Buy.
That average rating earns LYEL an Analyst Ranking of 30, which means it ranks higher than 30 of stocks, based on data compiled by InvestorsObserver.
Wall Street analysts are rating LYEL a Buy today. Find out what this means to you and get the rest of the rankings on LYEL!
Analytical research by professionals can be extremely useful when making investment decisions in the stock market. Analysts are able to observe industries in detail and learn how geographical impacts can affect a company's balance sheet. This information allows investors to make decisions ahead of the curve.
InvestorsObserver combines the ratings from these analysts and proceeds to percentile rank them. This grants you the ability to compare stocks in a comprehensive fashion as oppossed to a standard buy/hold/sell rating.
What's Happening With Lyell Immunopharma Inc Stock Today?
Lyell Immunopharma Inc (LYEL) stock is trading at $1.78 as of 11:54 AM on Wednesday, Nov 22, a rise of $0.01, or 0.57% from the previous closing price of $1.77. The stock has traded between $1.76 and $1.93 so far today. Volume today is less active than usual. So far 223,258 shares have traded compared to average volume of 989,617 shares.
Click Here to get the full Stock Report for Lyell Immunopharma Inc stock.
Share this article:
Stay In The Know
Subscribe to our daily morning update newsletter and never miss out on the need-to-know market news, movements, and more.
Thank you for signing up! You're all set to receive the Morning Update newsletter
